Wealthcare Advisory Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-287
| Closed | -$204K | – | 943 |
|
|
2024
Q4 | $204K | Sell |
287
-11
| -4% | -$7.84K | 0.01% | 857 |
|
|
2024
Q3 | $313K | Buy |
298
+1
| +0.3% | +$1.05K | 0.01% | 706 |
|
|
2024
Q2 | $312K | Buy |
297
+3
| +1% | +$3.15K | 0.01% | 661 |
|
|
2024
Q1 | $283K | Buy |
294
+37
| +14% | +$35.6K | 0.01% | 689 |
|
|
2023
Q4 | $226K | Buy |
+257
| New | +$226K | 0.01% | 685 |
|
|
2021
Q2 | – | Sell |
-91
| Closed | -$43K | – | 1562 |
|
|
2021
Q1 | $43K | Buy |
+91
| New | +$43K | ﹤0.01% | 928 |
|
|
2019
Q3 | – | Sell |
-40
| Closed | -$13K | – | 1402 |
|
|
2019
Q2 | $13K | Sell |
40
-15
| -27% | -$4.88K | ﹤0.01% | 848 |
|
|
2019
Q1 | $23K | Hold |
55
| – | – | ﹤0.01% | 625 |
|
|
2018
Q4 | $21K | Sell |
55
-28
| -34% | -$10.7K | ﹤0.01% | 617 |
|
|
2018
Q3 | $34K | Buy |
83
+15
| +22% | +$6.15K | 0.01% | 553 |
|
|
2018
Q2 | $23K | Hold |
68
| – | – | ﹤0.01% | 641 |
|
|
2018
Q1 | $23K | Sell |
68
-1
| -1% | -$338 | 0.01% | 556 |
|
|
2017
Q4 | $26K | Buy |
69
+44
| +176% | +$16.6K | 0.01% | 486 |
|
|
2017
Q3 | $11K | Buy |
+25
| New | +$11K | ﹤0.01% | 528 |
|